QuidelOrtho Corp

NASDAQ:QDELUnited States

QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.

Contact Information

Headquarters

9975 Summers Ridge RoadSAN DIEGO, CA, United States 92121

Phone

858-552-1100

Fax

858-453-4338

Executives

Lead Independent Director

Kenneth Buechler

President, Chief Executive Officer

Brian Blaser

Chief Financial Officer

Joseph Busky

Interim President, Chief Operating Officer, Executive Vice President

Robert Bujarski

Interim Chief Executive Officer, Executive Vice President, Chief Commercial Officer

Michael Iskra